Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models-Reference-Cited by-同舟云学术

Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models

Published:2015-03-29 Issue:16 Volume:6 Page:14247-14259
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shao Haibo¹,Zhang Jian²,Sun Ziping³,Chen Feng⁴,Dai Xu¹,Li Yaming¹,Ni Yicheng¹²³⁴,Xu Ke¹

Affiliation:

1. Department of Radiology, The First Hospital of China Medical University, Shenyang, China

2. Laboratory of Translational Medicine, Jiangsu Provincial Academy of Traditional Chinese Medicine, Nanjing, China

3. Radiation Medical Institute, Shandong Academy of Medical Sciences, Jinan, China

4. Department of Imaging & Pathology, Theragnostic Laboratory, University of Leuven, Leuven, Belgium

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation;Molecular Pharmaceutics;2024-03-07

2. Hypericin: A natural anthraquinone as promising therapeutic agent;Phytomedicine;2023-03

3. Radioiodinated hypericin as a tracer for detection of acute myocardial infarction: SPECT-CT imaging in a swine model;Journal of Nuclear Cardiology;2022-03-16

4. Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies;Technology in Cancer Research & Treatment;2022-01

5. Preparation and validation of cyclodextrin-based excipients for radioiodinated hypericin applied in a targeted cancer radiotherapy;International Journal of Pharmaceutics;2021-04